ANUREKHA B CHADHA MD NPI 1548256845

NPI Information

  • NPI: 1548256845
  • Provider Name: ANUREKHA B CHADHA, MD
  • Classification: Internal Medicine - 207RR0500X
  • Specialization: Rheumatology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 6811 AUSTIN CENTER BLVD #300
    AUSTIN, TX
    ZIP 78731
  • Phone: (512) 346-8888

Map and Directions

Get Directions

NPI Details

Anurekha B Chadha, MD is a rheumatology internal medicine in Austin, TX with 30 years of experience. The provider is an internist who treats diseases of joints, muscle, bones and tendons. This specialist diagnoses and treats arthritis, back pain, muscle strains, common athletic injuries and collagen diseases. Anurekha B Chadha, MD NPI is 1548256845. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

Education
Medical School: UNIVERSITY OF MISSOURI, KANSAS CITY, SCHOOL OF MEDICINE
Graduation Year:1996

The provider's business location address is:

6811 AUSTIN CENTER BLVD #300
AUSTIN, TX
ZIP 78731-166
Phone: (512) 346-8888
Fax: (512) 344-0350

The NPI 1548256845 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0717)
  • Injection, golimumab, 1 mg, for intravenous use (HCPCS:J1602)
  • Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0129)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, infliximab, excludes biosimilar, 10 mg (HCPCS:J1745)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Measurement c-reactive protein for detection of infection or inflammation (HCPCS:86140)
  • Red blood cell sedimentation rate, to detect inflammation, automated (HCPCS:85652)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
  • Measurement of dna antibody, native or double stranded (HCPCS:86225)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Administration of influenza virus vaccine (HCPCS:G0008)
  • Manual urinalysis test with examination using microscope, automated (HCPCS:81001)
  • Influenza vaccine split virus, preservative free (HCPCS:90662)
  • Injection, zoledronic acid, 1 mg (HCPCS:J3489)
  • Tuberculosis test, gamma interferon (HCPCS:86480)
  • X-ray of hand, minimum of 3 views (HCPCS:73130)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Automated urinalysis test (HCPCS:81003)
  • Fee covid-19 vac 14 res (HCPCS:0134A)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Vitamin d-3 level (HCPCS:82306)
  • Creatine kinase (cardiac enzyme) level, total (HCPCS:82550)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Measure of severe acute respiratory syndrome coronavirus 2 (covid-19) antibody (HCPCS:86769)
  • Measurement of antibody for rheumatoid arthritis assessment (HCPCS:86200)
  • Rheumatoid factor level (HCPCS:86431)
  • Coronavirus vaccine 14 (HCPCS:91313)
  • Screening test for autoimmune disorder (HCPCS:86038)
  • Fee covid-19 vac 13 res (HCPCS:0124A)
  • Bacterial colony count, urine (HCPCS:87086)
  • Measurement of antibody for assessment of autoimmune disorder, titer (HCPCS:86039)
  • Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
  • Coronavirus vaccine 13 (HCPCS:91312)
  • Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)

The enumeration date for this NPI number is 9/22/2005 and was last updated on 12/15/2010.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207R00000XInternal MedicineM3972TEXASNo
2207RR0500XInternal MedicineRheumatologyM3972TEXASYes

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.

No. Other Provider Identifier Other Provider Identifier Type Other Provider Identifier State Other Provider Identifier Issuer
1P00656762MEDICARE PINTEXAS
2036100202MEDICAIDILLINOIS
38J2631MEDICARE PINTEXAS
48J2632MEDICARE PINTEXAS
5H57314MEDICARE UPINILLINOIS
6186761602MEDICAIDTEXAS
7L92491MEDICARE PINILLINOIS
8186761601MEDICAIDTEXAS
9L92489MEDICARE PINILLINOIS
10L92490MEDICARE PINILLINOIS

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.